Uvax Bio Announces Dosing of First Participant in Phase 1 Clinical Trial Evaluating Two Vaccines to Prevent HIV-1 Infection
Study to assess safety and immunogenicity of novel protein nanoparticle vaccine candidates UVAX-1107 and UVAX-1197…
Study to assess safety and immunogenicity of novel protein nanoparticle vaccine candidates UVAX-1107 and UVAX-1197…
ROSEBURG, Ore. & SINGAPORE--(BUSINESS WIRE)--Diode, the innovation leader in Zero Trust Network Access software, and…
Despite reported threat detection, investigation, and response (TDIR) improvements in security operations, more than half…
DigiLens and Kaynes join forces to revolutionize Augmented Reality and mobile computing in APAC, and…
Innovative out-of-the-box security solution for OpenBMC users takes a major step towards eliminating supply chain…
Motor Control Leader Debuts RA8T1 Group MCUs Based on Arm® Cortex®-M85 Processor to Deliver Low…
Updated branding reflects next step in company’s journey to deliver innovative digital financial solutions to…
SAN ANTONIO--(BUSINESS WIRE)--#BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need…
Companies can now analyze and progress their disability inclusion efforts in Brazil, Canada, Germany, India,…
TruBot RPA Chosen for a Two-Year Framework Contract Based on 'Best Value for Money' MUMBAI,…